State ADAP Drug Formulary Patient Advisory Committee

Quick links

Committee Members • Committee Meetings • Committee Policy Assets • Committee Resources • Disclosures

Committee Members

ADAP Advocacy is currently recruiting patients and public health stakeholders to serve on its State ADAP Drug Formulary Patient Advisory Committee.

Download Member Directory

The committee is open to adding new discussion topics to its meeting agenda. Click here to submit your thoughts to Rev. Alexander Garbera, chair of the State ADAP Drug Formulary Patient Advisory Committee.

March 23, 2026

June 9, 2025

BACK TO TOP

Committee Meetings

AIDS Drug Assistance Programs

BACK TO TOP

Committee Policy Assets

Health Resources Services Administration (HRSA)

According to the Health Resources Services Administration (HRSA), Ryan White HIV/AIDS Program (RWHAP) legislation and HRSA HIV/AIDS Bureau (HAB) have established the following requirements for drug formularies under Part B: AIDS Drug Assistance Program (ADAP):

  • An ADAP formulary must include at least one drug from each class of HIV antiretroviral medications.

  • RWHAP funds may only be used to purchase medications approved by the FDA and the devices needed to administer them.

  • An ADAP formulary must be consistent with the most recent HHS treatment guidelines.

  • All therapeutic treatment and ancillary devices (e.g., syringes to administer an ADAP formulary medication) included on the ADAP formulary and all ADAP-funded services must be equally and consistently available to all eligible enrolled individuals throughout the state/territory.

Committee Resources

Learn more

National Alliance of State & Territorial AIDS Directors (NASTAD)

BACK TO TOP

This project is funded by the following corporate entities:
AIDS Alabama, Gilead Sciences, MedData Service, Merck, Patient Advocate Foundation, Ramsell Corporation, ScriptGuideRx, and ViiV Healthcare.

Transparency statement:
To read our Transparency Statement, click here.

BACK TO TOP

Disclosures